Calamos Advisors LLC Novo Nordisk A S Call Options Transaction History
Calamos Advisors LLC
- $15.7 Billion
- Q1 2025
Call Options
1 transactions
Others Institutions Holding NVO
# of Institutions
1,856Shares Held
339MCall Options Held
12MPut Options Held
10.6M-
Jennison Associates LLC19.9MShares$1.3 Billion1.06% of portfolio
-
Bank Of America Corp Charlotte, NC15.5MShares$1.01 Billion0.11% of portfolio
-
Gqg Partners LLC Ft. Lauderdale, FL13MShares$847 Million1.67% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$824 Million0.44% of portfolio
-
Morgan Stanley New York, NY12.2MShares$795 Million0.08% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $147B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...